Back to search
FDAFDA · Food and drugs·Recall number Z-2223-2026

LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005.

Published June 10, 2026 · Recall initiated: May 6, 2026

Summary

FDA records medical device Class I recall Z-2223-2026, published June 10, 2026 and initiated May 6, 2026. Recalling firm: Fresenius Kabi USA, LLC; Status: Ongoing; Reported quantity: 32 systems; Lot: Product Code LVP-SW-0005. UDI-DI: 00811505030122. Software Version 5.10.2. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Potential software anomaly that can cause the pump to report a false battery-health value (typically 69%) and trigger a battery-depletion alarm that will shut down the pump unless it is reconnected to AC mains power.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Fresenius Kabi USA, LLC
Distributor
US Nationwide distribution in the states of CA, CO, FL, GA, GA, ID, IL, MD, MI, MN, MO, MS, NE, NJ, NV, OK, OR, SC, TX, VA, WA, WI.
Lot
Product Code LVP-SW-0005. UDI-DI: 00811505030122. Software Version 5.10.2
Risk classification
Class I
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was LVP software of the Ivenix Infusion System (IIS); Product Code LVP-SW-0005. recalled?

Yes. FDA published recall Z-2223-2026 on June 10, 2026. Reported hazard: Potential software anomaly that can cause the pump to report a false battery-health value (typically 69%) and trigger a battery-depletion alarm that will shut down the pump unless it is reconnected to AC mains power.

What should I do if I have this product?

Voluntary: Firm initiated · Letter